bortezomib - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
BORTEZOMIB ACCORD bortezomib 3.5 mg/1.4 mL solution for injection vial
AUST R: 369472
Active ingredients:
bortezomib

Dosage form:
Injection, solution

Sponsor:
Accord Healthcare Pty Ltd

Phone:
1800 222 673

From
30 Apr 2025
to
31 Jul 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Alternative generic products are available.

DBL BORTEZOMIB 2.5 mg powder for injection vial
AUST R: 275710
Active ingredients:
bortezomib

Dosage form:
Injection, powder for

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

Deletion from market:
01 Oct 2024

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
An alternative product is available.

DBL Bortezomib bortezomib 1.0 mg powder for injection vial
AUST R: 313359
Active ingredients:
bortezomib

Dosage form:
Injection, powder for

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

Deletion from market:
01 Oct 2024

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
An alternative product is available.

VELCADE bortezomib 3.5 mg powder for injection vial
AUST R: 104542
Active ingredients:
bortezomib

Dosage form:
Injection, powder for

Sponsor:
Janssen-Cilag Pty Ltd

Phone:
1800226334

Deletion from market:
30 Jun 2025

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic products are available.